Allergen-specific immunotherapy and evidence: A European regulatory perspective.
- DOI
- 10.5414/alx02413e
- Published
- 2023
- Container
- Allergologie select
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5414/alx02413e,
title = {Allergen-specific immunotherapy and evidence: A European regulatory perspective.},
author = {Bartel D and Bonertz A and Hartenstein D and Kaul S and Lauer I and Reeb C and Rösner-Friese K and Sliva K and Zimmer J and Vieths S and Mahler V},
year = {2023},
journal = {Allergologie select},
doi = {10.5414/alx02413e},
url = {https://doi.org/10.5414/alx02413e}
}RIS
TY - JOUR TI - Allergen-specific immunotherapy and evidence: A European regulatory perspective. AU - Bartel D AU - Bonertz A AU - Hartenstein D AU - Kaul S AU - Lauer I AU - Reeb C AU - Rösner-Friese K AU - Sliva K AU - Zimmer J AU - Vieths S AU - Mahler V PY - 2023 JO - Allergologie select DO - 10.5414/alx02413e UR - https://doi.org/10.5414/alx02413e ER -
APA
D, B., A, B., D, H., S, K., I, L., C, R., K, R., K, S., J, Z., S, V., & V, M. (2023). Allergen-specific immunotherapy and evidence: A European regulatory perspective.. Allergologie select. https://doi.org/10.5414/alx02413e
Source records
- pubmed · retrieved 2026-09-26T04:09:28.325Z